WA
IONS icon

WPG Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

WPG Advisers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.17K Buy
103
+33
+47% +$2.48K ﹤0.01% 830
2026
Q1 		$5.26K Hold
70
– – ﹤0.01% 863
2025
Q4 		$5.54K Hold
70
– – ﹤0.01% 876
2025
Q3 		$4.58K Hold
70
– – ﹤0.01% 929
2025
Q2 		$2.77K Buy
+70
New +$2.29K ﹤0.01% 1044

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

WPG Advisers's IONS Position: Q2 2026 in Review

WPG Advisers increased its Ionis Pharmaceuticals (IONS) stake by 47% in Q2 2026, buying an estimated $2.48K and bringing the position to 103 shares worth $8.17K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

WPG Advisers first reported a position in IONS in Q2 2025 and has held it in 5 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • WPG Advisers held 103 shares of Ionis Pharmaceuticals worth $8.17K as of Q2 2026.
  • WPG Advisers bought 33 Ionis Pharmaceuticals shares in Q2 2026, an estimated $2.48K.
  • Ionis Pharmaceuticals made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #830 holding.
  • WPG Advisers first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.